10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2013 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2013 10-K (Filed: Feb 21, 2014) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2013 | Dec 31, 2012 | |
Assets | ||
Current Assets: | ||
Cash and cash equivalents | $ 3,475 | 10,802 |
Investments, primarily bank time deposits and U.S. treasury bills | 4,623 | 4,372 |
Trade receivables, less allowances of - 2013: $312; 2012: $406 | 3,986 | 7,613 |
Inventories: | ||
Finished products | 1,866 | 2,346 |
Work in process | 349 | 629 |
Materials | 478 | 818 |
Total inventories | 2,693 | 3,793 |
Deferred income taxes | 2,528 | 2,986 |
Other prepaid expenses and receivables | 1,504 | 1,757 |
Current assets held for disposition | 438 | |
Total Current Assets | 19,247 | 31,323 |
Investments | 119 | 274 |
Property and Equipment, at Cost: | ||
Land | 502 | 605 |
Buildings | 2,994 | 4,259 |
Equipment | 8,506 | 13,111 |
Construction in progress | 868 | 954 |
Property and Equipment, at Cost | 12,870 | 18,929 |
Less: accumulated depreciation and amortization | 6,965 | 10,866 |
Net Property and Equipment | 5,905 | 8,063 |
Intangible Assets, net of amortization | 5,735 | 8,588 |
Goodwill | 9,772 | 15,774 |
Deferred Income Taxes and Other Assets | 2,109 | 3,213 |
Non-current Assets Held for Disposition | 66 | |
Total Assets | 42,953 | 67,235 |
Liabilities and Shareholders' Investment | ||
Current Liabilities: | ||
Short-term borrowings | 3,164 | 2,082 |
Trade accounts payable | 1,026 | 1,797 |
Salaries, wages and commissions | 906 | 1,428 |
Other accrued liabilities | 3,500 | 6,788 |
Dividends payable | 341 | 221 |
Income taxes payable | 175 | 655 |
Current portion of long-term debt | 9 | 309 |
Current liabilities held for disposition | 386 | |
Total Current Liabilities | 9,507 | 13,280 |
Long-term Debt | 3,388 | 18,085 |
Post-employment Obligations and Other Long-term Liabilities | 4,784 | 9,057 |
Non-current Liabilities Held for Disposition | 7 | |
Commitments and Contingencies | ||
Shareholders' Investment: | ||
Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2013: 1,685,827,096; 2012: 1,675,930,484 | 12,048 | 11,755 |
Common shares held in treasury, at cost - Shares: 2013: 137,728,810; 2012: 99,262,992 | (6,844) | (5,591) |
Earnings employed in the business | 21,979 | 24,151 |
Accumulated other comprehensive income (loss) | (2,012) | (3,594) |
Total Abbott Shareholders' Investment | 25,171 | 26,721 |
Noncontrolling Interests in Subsidiaries | 96 | 92 |
Total Shareholders' Investment | 25,267 | 26,813 |
Total Liabilities and Shareholders' Investment | 42,953 | 67,235 |
External Links | |
ABBOTT LABORATORIES (ABT) Fiscal Year 2013 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |